Skip to main content

Prognosis in Infective Endocarditis

  • Chapter
  • First Online:

Abstract

Despite diagnostic and therapeutic improvements, infective endocarditis remains associated with high mortality and severe complications. When assessing the prognosis of patients with endocarditis, three different clinical periods should be distinguished: prognostic assessment at admission, early risk reassessment during the first week of antibiotics, and short and long-term prognosis after discharge. The three cornerstones for diagnosis and prognosis of patients with endocarditis are based on physical examination (signs of heart failure), echocardiography (periannular complications), and blood cultures (S. aureus infection). These predictors can be available in the first 72 h after admission. Besides the above mentioned three clinical periods, for those patients who require surgical treatment in the active phase of the disease, an accurate surgical risk score would help to recognize which patients have a high risk and should not be sent to surgery.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.

    Article  PubMed  Google Scholar 

  2. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32(16):2027–33.

    Article  PubMed  Google Scholar 

  3. Chu VH, Cabell CH, Benjamin Jr DK, Kuniholm EF, Fowler Jr VG, Engemann J, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745–9.

    Article  PubMed  Google Scholar 

  4. San Román JA, López J, Vilacosta I, Luaces M, Sarriá C, Revilla A, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120(4):369.e1–7.

    Article  Google Scholar 

  5. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis. Risk classification for mortality. JAMA. 2003;289(15):1933–40.

    Article  PubMed  Google Scholar 

  6. Granowitz E, Longworth DL. Risk stratification and bedside prognostication in infective endocarditis. JAMA. 2003;289(15):1991–3.

    Article  PubMed  Google Scholar 

  7. Mansur AJ, Grinberg M, Cardoso HA, da Luz PL, Bellotti G, Pileggi F. Determinants of prognosis in 300 episodes of infective endocarditis. Thorac Cardiovasc Surg. 1996;44(1):2–10.

    Article  CAS  PubMed  Google Scholar 

  8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, CooK D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–6.

    Article  PubMed  Google Scholar 

  9. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754–8.

    Article  CAS  PubMed  Google Scholar 

  10. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.

    Article  CAS  PubMed  Google Scholar 

  11. Ferrera C, Vilacosta I, Fernández C, López J, Sarriá C, Olmos C, et al. Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis. Am J Cardiol. 2015;115(7):950–5.

    Article  PubMed  Google Scholar 

  12. Sy RW, Chawantanpipat C, Richmond D, Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824–5.

    Article  PubMed  Google Scholar 

  13. Nadji G, Rusinaru D, Remadi JP, Jeu A, Sorel C, Tribouilloy C. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11(7):668–75.

    Article  PubMed  Google Scholar 

  14. Olmos C, Vilacosta I, Fernández C, López J, Sarriá C, Ferrera C, et al. Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J. 2013;34(26):1999–2006.

    Article  CAS  PubMed  Google Scholar 

  15. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A, et al. Neurological complications of infective endocarditis. Risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272–84.

    Article  PubMed  Google Scholar 

  16. Delahaye F, Alla F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis. 2007;39(10):849–57.

    Article  PubMed  Google Scholar 

  17. Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, et al. Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J. 2007;28(1):59–64.

    Article  PubMed  Google Scholar 

  18. Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Lucà F, et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg. 2012;93(5):1469–76.

    Article  PubMed  Google Scholar 

  19. Olmos C, Vilacosta I, Pozo E, Fernández C, Sarriá C, López J, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: findings from a large cohort study. Medicine (Baltimore). 2014;93(2):114–9.

    Article  Google Scholar 

  20. López J, Revilla A, Vilacosta I, Sevilla T, Villacorta E, Sarriá C, et al. Age-dependent profile of left-sided infective endocarditis. A 3-center experience. Circulation. 2010;121(7):892–7.

    Article  PubMed  Google Scholar 

  21. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am. 2001;15(2):407–21.

    Article  CAS  PubMed  Google Scholar 

  22. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.

    Article  CAS  PubMed  Google Scholar 

  23. Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J Diabetes Complications. 2007;21(6):403–6.

    Article  PubMed  Google Scholar 

  24. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102(23):2842–8.

    Article  CAS  PubMed  Google Scholar 

  25. Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19(3):312–20.

    PubMed  Google Scholar 

  26. Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis. 2006;38(8):613–9.

    Article  PubMed  Google Scholar 

  27. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001;24(6):1044–9.

    Article  CAS  PubMed  Google Scholar 

  28. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler Jr VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009;169(5):463–73.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mourviller B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Regnier B, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004;30(11):2046–52.

    Article  Google Scholar 

  30. Parrino PE, Kron IL, Ross SD, Shockey KS, Kron AM, Towler MA, et al. Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann Thorac Surg. 1999;67(1):59–64.

    Article  CAS  PubMed  Google Scholar 

  31. Chou M-T, Wang J-J, Wu W-S, Weng S-F, Ho C-H, Lin Z-Z, et al. Epidemiologic features and long-term outcome of dialysis patients with infective endocarditis in Taiwan. Int J Cardiol. 2015;179:465–9.

    Article  PubMed  Google Scholar 

  32. Maraj S, Jacobs LE, Maraj R, Kotler MN. Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci. 2004;327(5):242–9.

    Article  PubMed  Google Scholar 

  33. Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant. 2004;19(6):1360–2.

    Article  PubMed  Google Scholar 

  34. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999;55(3):1081–90.

    Article  CAS  PubMed  Google Scholar 

  35. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci. 2003;325(4):237–42.

    Article  PubMed  Google Scholar 

  36. Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44(6):1077–82.

    Article  PubMed  Google Scholar 

  37. Jones DA, McGill LA, Rathod KS, Matthews K, Gallagher S, Uppal R, et al. Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract. 2013;123(3–4):151–6.

    Article  CAS  PubMed  Google Scholar 

  38. Fernández-Cean J, Álvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic hemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17(12):2226–30.

    Article  PubMed  Google Scholar 

  39. Leither MD, Shroff GR, Ding S, Gilbertson DT, Herzog CA. Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation. 2013;128(4):344–51.

    Article  PubMed  Google Scholar 

  40. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation. 2002;105(11):1336–41.

    Article  PubMed  Google Scholar 

  41. Thuny F, Habib G. When should we operate on patients with acute infective endocarditis? Heart. 2010;96(11):892–7.

    Article  PubMed  Google Scholar 

  42. Vilacosta I, Graupner C, San Román JA, Sarriá C, Ronderos R, Fernández C, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39(9):1489–95.

    Article  PubMed  Google Scholar 

  43. López J, Sevilla T, Vilacosta I, Sarriá C, Revilla A, Ortiz C, et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2013;34(23):1749–54.

    Article  PubMed  Google Scholar 

  44. Revilla A, López J, Vilacosta I, Villacorta E, Rollán MJ, Echevarría JR, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J. 2007;28(1):65–71.

    Article  PubMed  Google Scholar 

  45. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003;290(24):3207–14.

    Article  CAS  PubMed  Google Scholar 

  46. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis. 2007;44(3):364–72.

    Article  PubMed  Google Scholar 

  47. Mestres CA, Castro MA, Bernabeu E, Josa M, Cartaná R, Pomar JL, et al. Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results. Eur J Cardiothorac Surg. 2007;32(2):281–5.

    Article  PubMed  Google Scholar 

  48. Rasmussen RV, Bruun LE, Lund J, Larsen CT, Hassager C, Bruun NE. The impact of cardiac surgery in native valve infective endocarditis: can EuroSCORE guide patient selection? Int J Cardiol. 2011;149(3):304–9.

    Article  PubMed  Google Scholar 

  49. Wang TKM, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Comparison of contemporary risk scores for predicting outcomes after surgery for infective endocarditis. Heart Vessels. 2014;30(2):227–34.

    Article  PubMed  Google Scholar 

  50. Shahian DM, O’Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of thoracic surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2–22.

    Article  PubMed  Google Scholar 

  51. Gaca JG, Sheng S, Daneshmand MA, O’Brien S, Scott Rankin J, Matthew Brennan J, et al. Outcomes for endocarditis surgery in North America: A simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141(1):98–106.

    Article  PubMed  Google Scholar 

  52. De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. Sci World J. 2012;2012:307571.

    Google Scholar 

  53. Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. Int J Cardiol. 2014;175(1):133–7.

    Article  PubMed  Google Scholar 

  54. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis. A prospective study from the International Collaboration on Endocarditis. Circulation. 2015;131(2):131–40.

    Article  PubMed  Google Scholar 

  55. Olmos C, Vilacosta I, Sarriá C, Fernández C, López J, Ferrera C, et al. Characterization and clinical outcome of patients with possible infective endocarditis. Int J Cardiol. 2015;178:31–3.

    Article  PubMed  Google Scholar 

  56. Chee Q-Z, Tan Y-QB, Ngiam JN, Win MTM, Shen X, Choo J-NJ, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: An 11-year study. Int J Cardiol. 2015;191:273–6.

    Article  PubMed  Google Scholar 

  57. Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, et al. Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis. Eur Heart J. 2014;35(18):1195–204.

    Article  PubMed  Google Scholar 

  58. Shih C-J, Chu H, Chao P-W, Lee Y-J, Kuo S-C, Li S-Y, et al. Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study. Circulation. 2014;130(19):1684–91.

    Article  PubMed  Google Scholar 

  59. Gálvez-Acebal J, Almendro-Delia M, Ruiz J, de Alarcón A, Martínez-Marcos FJ, Reguera JM, et al. Influence of early surgical treatment on the prognosis of left-sided infective endocarditis: a multicenter cohort study. Mayo Clin Proc. 2014;89(10):1397–405.

    Article  PubMed  Google Scholar 

  60. Alagna L, Park LP, Nicholson BP, Keiger AJ, Strahilevitz J, Morris A, et al. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2014;20(6):566–75.

    Article  CAS  PubMed  Google Scholar 

  61. Kaiser SP, Melby SJ, Zierer A, Schuessler RB, Moon MR, Moazami N, et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg. 2007;83(1):30–5.

    Article  PubMed  Google Scholar 

  62. Heiro M, Helenius H, Makila S, Hohenthal U, Savunen T, Engblom E, et al. Infective endocarditis in a finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart. 2006;92(10):1457–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Heiro M, Helenius H, Hurme S, Savunen T, Metsärinne K, Engblom E, et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis. 2008;8:49.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Fedoruk LM, Jamieson WR, Ling H, MacNab JS, Germann E, Karim SS, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg. 2009;137(2):326–33.

    Article  PubMed  Google Scholar 

  65. David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg. 2007;133(1):144–9.

    Article  PubMed  Google Scholar 

  66. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–132.

    Article  PubMed  Google Scholar 

  67. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.

    Article  PubMed  Google Scholar 

  68. Martínez-Sellés M, Muñoz P, Estevez A, del Castillo R, García-Fernández MA, Rodríguez-Creixems M, et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc. 2008;83(11):1213–7.

    Article  PubMed  Google Scholar 

  69. Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect. 2012;18(12):E522–30.

    Article  PubMed  Google Scholar 

  70. Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, Casalta JP, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J. 2012;164(1):94–101.

    Article  PubMed  Google Scholar 

  71. Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg. 2011;91(5):1407–12.

    Article  PubMed  Google Scholar 

  72. Ternhag A, Cederstrom A, Torner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8(7):e67519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32(16):2003–15.

    Article  PubMed  Google Scholar 

  74. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11:48.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isidre Vilacosta MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Vilacosta, I. et al. (2016). Prognosis in Infective Endocarditis. In: Habib, G. (eds) Infective Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-32432-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32432-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32430-2

  • Online ISBN: 978-3-319-32432-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics